K.J. Harrison & Partners’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-8,495
Closed -$658K 376
2021
Q4
$658K Buy
8,495
+5
+0.1% +$513 0.09% 180
2021
Q3
$913K Sell
8,490
-1,000
-11% -$115K 0.13% 163
2021
Q2
$1.27K Buy
9,490
+6,040
+175% +$702K 0.13% 141
2021
Q1
$427K Sell
3,450
-2,000
-37% -$304K 0.07% 201
2020
Q4
$770K Sell
5,450
-3,850
-41% -$427K 0.13% 175
2020
Q3
$707K Buy
+9,300
New +$579K 0.15% 144
2019
Q3
Sell
-15,000
Closed -$435K 172
2019
Q2
$435K Buy
+15,000
New +$397K 0.14% 114

Other funds holding TWST

K.J. Harrison & Partners's TWST Position: Q1 2022 in Review

K.J. Harrison & Partners sold out of Twist Bioscience (TWST) in Q1 2022, closing a stake of 8,495 shares — an estimated $658K sold.

K.J. Harrison & Partners first reported a position in TWST in Q2 2019 and held it in 7 quarters. The position peaked at $913K in Q3 2021. 212 funds tracked by Wall St. Rank hold TWST as of Q1 2022.

  • K.J. Harrison & Partners reported no remaining Twist Bioscience position as of Q1 2022 after selling out during the quarter.
  • K.J. Harrison & Partners sold 8,495 Twist Bioscience shares in Q1 2022, an estimated $658K.
  • K.J. Harrison & Partners first reported a position in Twist Bioscience in Q2 2019 and held it in 7 quarters.
  • K.J. Harrison & Partners's Twist Bioscience position peaked at $913K in Q3 2021.
  • 212 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2022.

Based on K.J. Harrison & Partners's 13F filing for Q1 2022, filed 21 Apr 2022.